PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.290
+0.040 (3.20%)
Apr 1, 2025, 4:00 PM EDT - Market closed
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.89 million as of April 1, 2025. Its market cap has decreased by -49.49% in one year.
Market Cap
8.89M
Enterprise Value
-8.14M
1-Year Change
-49.49%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.89M, a decrease of -47.71%. That is a compound annual growth rate of -5.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 8.60M | -21.10% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |